Balyasny Asset Management LLC Immuno Gen, Inc. Transaction History

Balyasny Asset Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $18.5 Million - $44.5 Million	1,484,838 Added 12456.69%	1,496,758 $44.4 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $14.4 Million - $20.3 Million	-1,020,659 Reduced 98.85%	11,920 $189,000
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $3.49 Million - $18.6 Million	929,828 Added 904.93%	1,032,579 $19.5 Million
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $1.04 Million - $1.4 Million	-284,043 Reduced 73.44%	102,751 $394,000
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $1.76 Million - $2.44 Million	386,794 New	386,794 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $345,684 - $632,108	109,741 New	109,741 $493,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $963,217 - $1.26 Million	-191,876 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $1.11 Million - $1.65 Million	191,876 New	191,876 $1.26 Million
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $774,590 - $1.42 Million	-430,328 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $427,155 - $1.05 Million	177,243 Added 70.03%	430,328 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $997,154 - $2.45 Million	253,085 New	253,085 $1.22 Million
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $647,578 - $826,479	-68,023 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $288,401 - $557,432	43,045 Added 172.33%	68,023 $716,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $126,638 - $197,825	24,978	24,978 $160,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.